Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2014
03/19/2014CN102558174B New pyrazolo[4,3-c]pyridine compound and synthesis method thereof
03/19/2014CN102333771B Indole derivatives as crth2 receptor antagonists
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674104 Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof
03/18/2014US8674103 Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making
03/18/2014US8674098 Compositions to effect neuronal growth
03/18/2014US8673932 Oxime substituted imidazo-containing compounds
03/18/2014US8673923 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
03/18/2014US8673900 Gamma secretase modulators
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2719538C Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
03/18/2014CA2632893C (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2014037750A1 Inhibitor compounds
03/13/2014WO2013192005A3 Differentiation of human embryonic stem cells into pancreatic endocrine cells
03/13/2014US20140073788 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds
03/13/2014US20140073787 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate.
03/13/2014US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
03/13/2014US20140073666 Compositions and methods for treatment
03/13/2014US20140073640 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/13/2014US20140073638 Ethynyl compounds useful for treatment of cns disorder
03/13/2014US20140073637 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
03/13/2014US20140073636 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
03/13/2014US20140073635 Substituted Imidazopyridinyl-Aminopyridine Compounds
03/13/2014US20140073631 Antiviral and antimicrobial compounds
03/13/2014US20140073621 5-alkynyl-pyrimidines
03/13/2014US20140072576 Chemokine receptor antagonists and use thereof
03/13/2014US20140072555 Inhibitor Compounds and Cancer Treatment Methods
03/13/2014US20140072517 Fe(ii) sequestering agents and uses thereof
03/12/2014EP2706059A1 Diazacarbazoles and methods of use
03/12/2014EP2705036A1 Tricyclic sulfonamide compounds and methods of making and using same
03/12/2014EP2705035A1 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
03/12/2014CN103635473A Dispiropyrrolidine derivative
03/12/2014CN103635472A Serine/threonine kinase inhibitors
03/12/2014CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof
03/12/2014CN103626770A Novel method for efficiently extracting total alkaloids from wild thermopsis lanceolata in Greater Khingan Mountains
03/12/2014CN103626769A Substituted sulfydryl hexahydric heteroaromatic imidazole derivative and preparation method and application thereof
03/12/2014CN103626768A New preparation process of moxifloxacin hydrochloride
03/12/2014CN103626767A Azaindole with regionselectivity and synthetic method thereof
03/12/2014CN103626766A Substituted heterocycle fused gamma-carbolines synthesis
03/12/2014CN103626765A Substituted azaindole compound and salt, composition and application thereof
03/12/2014CN103626764A Salt of harmol derivative
03/12/2014CN103626763A Phenanthroindolizidine (or phenanthroquinolizidine) alkaloid derivatives, preparation methods and anti-plant virus activities thereof
03/12/2014CN103626762A Benazepine compound and application thereof
03/12/2014CN103626761A Benazepine compound and application thereof as antitumor drug
03/12/2014CN103626760A Salt of harmine derivative derivative
03/12/2014CN103626759A Preparation method of apixaban intermediate
03/12/2014CN103626758A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103626757A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103626756A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103626755A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103626754A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103626753A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device
03/12/2014CN103623741A Graphene dispersing agent, preparation method thereof and preparation method of graphene
03/12/2014CN102584817B Preparation method of 2-(imidazo[1,2-a]pyridin-3-radical)acetic acid monohydrochloride and application thereof
03/12/2014CN102325754B Cyclic compound having hetero atom
03/12/2014CN102239168B Substituted piperidine spiro pyrrolidinone and piperidinones used as H3 modulators
03/12/2014CN101821266B Modulators of cystic fibrosis transmembrane conductance regulator
03/11/2014US8669368 Process for the preparation of cycloheptapyridine CGRP receptor antagonists
03/11/2014US8669366 Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
03/11/2014US8669365 Cyclopamine analogs
03/11/2014US8669289 Methods and compositions relating to hematologic malignancies
03/11/2014US8669271 Compounds, pharmaceutical compositions and uses thereof
03/11/2014US8669267 Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter
03/11/2014US8669264 Rutaecarpine derivatives for activating CYP1A2 in a subject
03/11/2014US8669263 Use of TAM receptor inhibitors as antimicrobials
03/11/2014US8669208 Herbicidal benzoxazinones
03/11/2014US8669081 Compositions useful as inhibitors of protein kinases
03/11/2014CA2617828C Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation methodthereof and use of same in
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014036502A2 Tetracycline compounds
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2014036015A1 Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
03/06/2014WO2014035967A2 Antagonists of chemokine receptors
03/06/2014WO2014035846A2 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
03/06/2014WO2014033597A1 5-azaindole compounds with anticancer and antiangiogenic activities
03/06/2014WO2014033560A1 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
03/06/2014WO2014033497A1 5-azaindole compounds with anticancer and antiangiogenic activities
03/06/2014WO2014008967A3 Materials for organic electroluminescent devices
03/06/2014WO2014007951A3 Substituted tricyclic compounds as fgfr inhibitors
03/06/2014US20140066626 Asymmetric synthesis method, related raw material and preparation method of (s,s)-2,8-diazabicyclo[4,3,0]nonane
03/06/2014US20140066453 Serine/threonine kinase inhibitors
03/06/2014US20140066449 Dipyridinium derivatives
03/06/2014US20140066434 Methods and Compositions for Treating Parkinson's Disease
03/06/2014US20140066433 Fused heterocyclic derivatives as s1p modulators
03/06/2014US20140066430 Aurora kinase modulators and method of use
03/06/2014US20140066420 Heterocyclic compound
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140065095 Novel inhibitors
03/05/2014EP2704225A1 Organic electroluminescent element
03/05/2014EP2703402A1 Pharmacologically active alicyclic n,n'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon
03/05/2014EP2703394A1 Novel 3-hydroxyisothiazole 1-oxide derivative
03/05/2014EP2702060A1 Acid addition salts of risperidone and pharmaceutical compositions thereof
03/05/2014EP2702059A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
03/05/2014EP2702058A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014CN103619986A Organic electroluminescence device
03/05/2014CN103619843A 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and use thereof in treating bacterial infections
03/05/2014CN103619842A Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 646